BiotechTube
Home/Neuronascent/Judith Kelleher-Andersson, Ph.D.
JK

Judith Kelleher-Andersson, Ph.D.

Founder, President, CEO, Director

Neuronascent

Therapeutic Areas

Alzheimer's DiseaseParkinson's DiseaseDevelopmental DelayVeterinary Neurology

Neuronascent Pipeline

DrugIndicationPhase
NNI-362 (NNI-351)Alzheimer's DiseasePhase 2

Leadership Team at Neuronascent

KN
Kenneth Narducy, Ph.D., MBA
Acting COO, Director
View full Neuronascent profile